AMOpportunities, Inc.
Formerly American Medical Opportunities Worldwide LLC
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2024 | $1 M | No. 4 | Under $2 million | debt, options | SEC | |
| Mar 2023 | $4 M | No. 3 | $2 to $10 million | equity | SEC | |
| Oct 2021 | $2 M | No. 2 | Under $2 million | equity | SEC | |
| Dec 2018 | $4 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
AMOpportunities, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2024).
SEC Form D · Dec 2024
The industry group it chose in its notices: Other Travel.
SEC Form D · Dec 2024
That is all the official record says: AMOpportunities, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of AMOpportunities, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 18 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Benjamin Bradley | Executive officer | Dec 2024 |
| Daniel David Flores | Executive officer | Dec 2024 |
| John David Danaher | Executive officer | Dec 2024 |
| Julia David Monfrini Peev | Executive officer | Dec 2024 |
| Kevin David Iverson | Executive officer | Dec 2024 |
| Kyle Swinsky | Executive officer | Dec 2024 |
| Mamta David Patel | Executive officer | Dec 2024 |
| Daniel Flores | Executive officer | Mar 2024 |
| Julia Monfrini Peev | Executive officer | Mar 2024 |
| Kelli Rojek | Executive officer | Oct 2021 |
| Malek Yala | Executive officer | Oct 2021 |
| Ouch Sereirath | Executive officer | Oct 2021 |
| Rojek Kelli | Executive officer | Nov 2020 |
| Charles Borom | Executive officer | Jan 2019 |
| Benjamin Bradley | Director | Dec 2024 |
| Jon David Willingham | Director | Dec 2024 |
| Kyle Swinsky | Director | Dec 2024 |
| Robert Saunders | Director | Dec 2024 |
| Mark Bakken | Director | Oct 2021 |
| Imran Ahmad | Director | Nov 2020 |
| Benjamin Bradley | Promoter | Dec 2024 |
| Kyle Swinsky | Promoter | Dec 2024 |